Senzime AB (publ) (SNZZF)
USD 0.53
(0.0%)
USD 0.53
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -139.54 Million SEK | -974.05% |
| 2022 | -12.99 Million SEK | 82.26% |
| 2021 | -73.23 Million SEK | 53.62% |
| 2020 | -157.91 Million SEK | -417.58% |
| 2019 | -30.51 Million SEK | 4.29% |
| 2018 | -31.87 Million SEK | -327.01% |
| 2017 | -7.46 Million SEK | 25.55% |
| 2016 | -10.02 Million SEK | 30.57% |
| 2015 | -14.44 Million SEK | -378.05% |
| 2014 | -3.02 Million SEK | 69.56% |
| 2013 | -9.92 Million SEK | -82.51% |
| 2012 | -5.43 Million SEK | -20.07% |
| 2011 | -4.52 Million SEK | -748.61% |
| 2010 | 698.16 Thousand SEK | -77.73% |
| 2009 | 3.13 Million SEK | 350.4% |
| 2008 | -1.25 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -56.11 Million SEK | 46.88% |
| 2024 Q1 | -105.63 Million SEK | 24.3% |
| 2023 Q4 | -139.54 Million SEK | -140.89% |
| 2023 FY | -139.54 Million SEK | -974.05% |
| 2023 Q3 | -57.92 Million SEK | -98.65% |
| 2023 Q2 | -29.16 Million SEK | 52.63% |
| 2023 Q1 | -61.56 Million SEK | -373.85% |
| 2022 Q3 | -43.72 Million SEK | 64.89% |
| 2022 Q4 | -12.99 Million SEK | 70.28% |
| 2022 FY | -12.99 Million SEK | 82.26% |
| 2022 Q2 | -124.52 Million SEK | -126.56% |
| 2022 Q1 | -54.96 Million SEK | 24.96% |
| 2021 Q4 | -73.23 Million SEK | 23.48% |
| 2021 Q1 | -140.91 Million SEK | 10.76% |
| 2021 Q2 | -116.8 Million SEK | 17.11% |
| 2021 Q3 | -95.71 Million SEK | 18.05% |
| 2021 FY | -73.23 Million SEK | 53.62% |
| 2020 Q4 | -157.91 Million SEK | -116.51% |
| 2020 Q3 | -72.93 Million SEK | 13.14% |
| 2020 Q1 | -23.99 Million SEK | 21.35% |
| 2020 FY | -157.91 Million SEK | -417.58% |
| 2020 Q2 | -83.97 Million SEK | -249.95% |
| 2019 FY | -30.51 Million SEK | 4.29% |
| 2019 Q3 | -38.92 Million SEK | -162.49% |
| 2019 Q4 | -30.51 Million SEK | 21.62% |
| 2019 Q1 | -20.75 Million SEK | 34.89% |
| 2019 Q2 | -14.83 Million SEK | 28.55% |
| 2018 Q2 | -20.24 Million SEK | 25.86% |
| 2018 Q4 | -31.87 Million SEK | -144.32% |
| 2018 Q1 | -27.31 Million SEK | -265.84% |
| 2018 FY | -31.87 Million SEK | -327.01% |
| 2018 Q3 | -13.04 Million SEK | 35.56% |
| 2017 Q2 | -19.48 Million SEK | -415.12% |
| 2017 FY | -7.46 Million SEK | 25.55% |
| 2017 Q3 | -14.82 Million SEK | 23.92% |
| 2017 Q1 | -3.78 Million SEK | 62.28% |
| 2017 Q4 | -7.46 Million SEK | 49.63% |
| 2016 Q1 | -11.93 Million SEK | 17.33% |
| 2016 Q2 | -7.97 Million SEK | 33.24% |
| 2016 Q4 | -10.02 Million SEK | 36.41% |
| 2016 FY | -10.02 Million SEK | 30.57% |
| 2016 Q3 | -15.76 Million SEK | -97.8% |
| 2015 Q4 | -14.44 Million SEK | 16.56% |
| 2015 Q2 | -19.41 Million SEK | -54.47% |
| 2015 Q1 | -12.56 Million SEK | -316.06% |
| 2015 FY | -14.44 Million SEK | -378.05% |
| 2015 Q3 | -17.3 Million SEK | 10.86% |
| 2014 Q3 | -5.72 Million SEK | 18.99% |
| 2014 Q4 | -3.02 Million SEK | 47.21% |
| 2014 FY | -3.02 Million SEK | 69.56% |
| 2014 Q2 | -7.06 Million SEK | -169.89% |
| 2014 Q1 | 10.1 Million SEK | 201.86% |
| 2013 Q1 | -1.7 Million SEK | 68.62% |
| 2013 Q2 | -1.7 Million SEK | 0.0% |
| 2013 FY | -9.92 Million SEK | -82.51% |
| 2013 Q4 | -9.92 Million SEK | 0.0% |
| 2012 Q2 | -2.21 Million SEK | 0.0% |
| 2012 Q4 | -5.43 Million SEK | 0.0% |
| 2012 FY | -5.43 Million SEK | -20.07% |
| 2011 FY | -4.52 Million SEK | -748.61% |
| 2011 Q2 | -4.6 Million SEK | 0.0% |
| 2011 Q4 | -4.52 Million SEK | 0.0% |
| 2010 Q4 | 698.16 Thousand SEK | 0.0% |
| 2010 Q2 | -386.39 Thousand SEK | 0.0% |
| 2010 FY | 698.16 Thousand SEK | -77.73% |
| 2009 Q4 | 3.13 Million SEK | 0.0% |
| 2009 FY | 3.13 Million SEK | 350.4% |
| 2008 FY | -1.25 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | -431.957% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -1993342.857% |
| Össur hf. | 395.08 Million USD | 135.32% |
| QHSLab, Inc. | 1.72 Million USD | 8166.094% |
| Wellstar International, Inc. | 51.36 Million USD | 371.655% |
| Össur hf. | 395.08 Million USD | 135.32% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 44302.467% |
| Aurora Spine Corporation | 1.9 Million USD | 7414.792% |
| BrainsWay Ltd. | -10.32 Million USD | -1252.141% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 1041.156% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 869.837% |
| Vivos Inc. | -1.59 Million USD | -8663.558% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 28733.604% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -25693.828% |
| Zecotek Photonics Inc. | 2.76 Million USD | 5151.349% |
| Avitar, Inc. | 5.17 Million USD | 2798.448% |
| Nanomix Corporation | 11.38 Million USD | 1325.209% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -2922.219% |
| Theraclion SA | -5.86 Million EUR | -2279.404% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 8372.136% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 8762.612% |
| Lombard Medical, Inc. | 11.49 Million USD | 1313.928% |
| ALR Technologies Inc. | 19.14 Million USD | 828.74% |
| Stratec SE | 119.12 Million USD | 217.139% |
| Vycor Medical, Inc. | 1.05 Million USD | 13352.298% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 253833.976% |
| MicroPort Scientific Corporation | 673.58 Million USD | 120.716% |
| VMS Rehab Systems, Inc. | 133.52 USD | 104509536.788% |
| NewCardio, Inc. | 2.41 Million USD | 5878.033% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 9612.004% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 22217.102% |
| Odyssey Group International, Inc. | 2.1 Million USD | 6720.236% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 21896.572% |
| Wellness Center USA, Inc. | 3.98 Million USD | 3601.232% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 562.869% |
| IR-Med Inc. | -606 Thousand USD | -22926.568% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -912.099% |
| Polarean Imaging plc | -5.94 Million USD | -2246.593% |
| United American Healthcare Corporation | -9.32 Million USD | -1396.097% |
| ECGI Holdings, Inc. | 3.17 Million USD | 4500.199% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 149831.742% |
| Capital Group Holdings, Inc. | -3508.00 USD | -3977693.615% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 53234.591% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 64520.982% |
| Urologix, Inc. | 4.61 Million USD | 3123.64% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 3414.967% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 4288.852% |
| SS Innovations International, Inc. | 1.18 Million USD | 11872.184% |
| Qualis Innovations, Inc. | 6671.00 USD | 2091855.359% |
| Smith & Nephew plc | 2.77 Billion USD | 105.023% |
| NIOX Group Plc | -23.93 Million USD | -483.063% |
| Fuse Medical, Inc. | 1.75 Million USD | 8048.812% |
| Broncus Holding Corporation | -81.42 Million USD | -71.374% |
| Brain Scientific Inc. | 2.11 Million USD | 6695.279% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 715.339% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 352859.309% |